Cardiovascular diseases are a group of disorders that occur in the heart and blood vessels and are the world’s leading cause of death. In vitro diagnostic (IVD) assays for detecting cardiac markers are essential tools to help treat or prevent CVD. Several protein markers are released into the blood when the heart is damaged or stressed. These protein markers support diagnosis of conditions including coronary heart disease, cerebrovascular disease, and deep vein thrombosis to guide therapeutic intervention. Several cardiovascular diseases such as hypertension, coronary artery stenosis, intrinsic cardiac dysfunction, acute ischemic myocardial injury, acute myocardial infarction, angiogenesis, artery lesions, atherosclerosis, blood pressure, congestive heart failure, Deep vein thrombosis (DVT), heart failure, hypertrophic cardiomyopathy, myocardial infarction, renal artery stenosis, restrictive and dilated cardiomyopathy, vascular inflammation and so on have been identified using specific marker. Detecting the quantity of marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.
Myeloperoxidase (MPO)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
---|---|---|---|---|---|---|---|---|
Human |
Myeloperoxidase |
GMP-h-MPO-Ag01 |
Myeloperoxidase (MPO) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in MPO level test of Cardiovascular disease (vascular inflammation) and related syndrome evaluation |
GMP-h-MPO-Ab01;GMP-h-MPO-Ab02:Anti-Human MPO mouse monoclonal antibody (mAb) |
Human Myeloperoxidase (MPO) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Myeloperoxidase (MPO) antibodies in MPO level test of Cardiovascular disease (vascular inflammation) and related syndrome evaluation. |
matrix metalloproteinase-3 (MMP3)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
---|---|---|---|---|---|---|---|---|
Human |
matrix metalloproteinase-3 |
GMP-h-MMP3-Ag01 |
matrix metalloproteinase-3 (MMP3) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in MMP3 level test of Cardiovascular disease (cancer, asthma and
rheumatoid arthritis) and related syndrome evaluation |
GMP-h-MMP3-Ab01;GMP-h-MMP3-Ab02:Anti-Human MMP3 mouse monoclonal antibody (mAb) |
Human matrix metalloproteinase-3 (MMP3) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other matrix metalloproteinase-3 (MMP3) antibodies in MMP3 level test of Cardiovascular disease (cancer, asthma and
rheumatoid arthritis) and related syndrome evaluation. |
Growth differentiation factor-15 (GDF-15)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
---|---|---|---|---|---|---|---|---|
Human |
Growth differentiation factor-15 |
GMP-h-GDF-15-Ag01 |
Growth differentiation factor-15 (GDF-15) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in GDF-15 level test of Cardiovascular disease (pressure overload,
myocardial infarction, heart failure, and atherosclerosis) and related syndrome evaluation |
GMP-h-GDF-15-Ab01;GMP-h-GDF-15-Ab02:Anti-Human GDF-15 mouse monoclonal antibody (mAb) |
Human Growth differentiation factor-15 (GDF-15) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Growth differentiation factor-15 (GDF-15) antibodies in GDF-15 level test of Cardiovascular disease (pressure overload,
myocardial infarction, heart failure, and atherosclerosis) and related syndrome evaluation. |
Creatine Kinase MB (CK-MB)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
---|---|---|---|---|---|---|---|---|
Human |
Creatine Kinase MB |
GMP-h-CK-MB-Ag01 |
Creatine Kinase MB (CK-MB) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CK-MB level test of Cardiovascular disease (Myocardial hypoxia) and related syndrome evaluation |
GMP-h-CK-MB-Ab01;GMP-h-CK-MB-Ab02:Anti-Human CK-MB mouse monoclonal antibody (mAb) |
Human Creatine Kinase MB (CK-MB) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Creatine Kinase MB (CK-MB) antibodies in CK-MB level test of Cardiovascular disease (Myocardial hypoxia) and related syndrome evaluation. |
Myoglobin (Myo)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
---|---|---|---|---|---|---|---|---|
Human |
Myoglobin |
GMP-h-Myo-Ag01 |
Myoglobin (Myo) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Myo level test of Cardiovascular disease (acute ischemic myocardial injury) and related syndrome evaluation |
GMP-h-Myo-Ab01;GMP-h-Myo-Ab02:Anti-Human Myo mouse monoclonal antibody (mAb) |
Human Myoglobin (Myo) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Myoglobin (Myo) antibodies in Myo level test of Cardiovascular disease (acute ischemic myocardial injury) and related syndrome evaluation. |
soluble ST2 (sST2)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
---|---|---|---|---|---|---|---|---|
Human |
soluble ST2 |
GMP-h-sST2-Ag01 |
soluble ST2 (sST2) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in sST2 level test of Cardiovascular disease (chronic and acute
heart failure) and related syndrome evaluation |
GMP-h-sST2-Ab01;GMP-h-sST2-Ab02:Anti-Human sST2 mouse monoclonal antibody (mAb) |
Human soluble ST2 (sST2) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other soluble ST2 (sST2) antibodies in sST2 level test of Cardiovascular disease (chronic and acute
heart failure) and related syndrome evaluation. |
creatine kinase myocardial band (CKMB)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
---|---|---|---|---|---|---|---|---|
Human |
creatine kinase myocardial band |
GMP-h-CKMB-Ag01 |
creatine kinase myocardial band (CKMB) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CKMB level test of Cardiovascular disease (acute?myocardial infarction) and related syndrome evaluation |
GMP-h-CKMB-Ab01;GMP-h-CKMB-Ab02:Anti-Human CKMB mouse monoclonal antibody (mAb) |
Human creatine kinase myocardial band (CKMB) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other creatine kinase myocardial band (CKMB) antibodies in CKMB level test of Cardiovascular disease (acute?myocardial infarction) and related syndrome evaluation. |
N-terminal prohormone of brain natriuretic peptide (NT-proBNP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
---|---|---|---|---|---|---|---|---|
Human |
N-terminal prohormone of brain natriuretic peptide |
GMP-h-NT-proBNP-Ag01 |
N-terminal prohormone of brain natriuretic peptide (NT-proBNP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in NT-proBNP level test of Cardiovascular disease (?congestive heart failure) and related syndrome evaluation |
GMP-h-NT-proBNP-Ab01;GMP-h-NT-proBNP-Ab02:Anti-Human NT-proBNP mouse monoclonal antibody (mAb) |
Human N-terminal prohormone of brain natriuretic peptide (NT-proBNP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other N-terminal prohormone of brain natriuretic peptide (NT-proBNP) antibodies in NT-proBNP level test of Cardiovascular disease (?congestive heart failure) and related syndrome evaluation. |
cardiac troponin T (cTnT)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
---|---|---|---|---|---|---|---|---|
Human |
cardiac troponin T |
GMP-h-cTnT-Ag01 |
cardiac troponin T (cTnT) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in cTnT level test of Cardiovascular disease (hypertrophic cardiomyopathy, restrictive and dilated cardiomyopathy.?) and related syndrome evaluation |
GMP-h-cTnT-Ab01;GMP-h-cTnT-Ab02:Anti-Human cTnT mouse monoclonal antibody (mAb) |
Human cardiac troponin T (cTnT) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other cardiac troponin T (cTnT) antibodies in cTnT level test of Cardiovascular disease (hypertrophic cardiomyopathy, restrictive and dilated cardiomyopathy.?) and related syndrome evaluation. |
Cardiac troponin I (cTnI)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
---|---|---|---|---|---|---|---|---|
Human |
Cardiac troponin I |
GMP-h-cTnI-Ag01 |
Cardiac troponin I (cTnI) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in cTnI level test of Cardiovascular disease (?myocardial infarction?) and related syndrome evaluation |
GMP-h-cTnI-Ab01;GMP-h-cTnI-Ab02:Anti-Human cTnI mouse monoclonal antibody (mAb) |
Human Cardiac troponin I (cTnI) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Cardiac troponin I (cTnI) antibodies in cTnI level test of Cardiovascular disease (?myocardial infarction?) and related syndrome evaluation. |
Heart-type Fatty Acid-Binding Protein (H-FABP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
---|---|---|---|---|---|---|---|---|
Human |
Heart-type Fatty Acid-Binding Protein |
GMP-h-H-FABP-Ag01 |
Heart-type Fatty Acid-Binding Protein (H-FABP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in H-FABP level test of Cardiovascular disease (myocardial injury) and related syndrome evaluation |
GMP-h-H-FABP-Ab01;GMP-h-H-FABP-Ab02:Anti-Human H-FABP mouse monoclonal antibody (mAb) |
Human Heart-type Fatty Acid-Binding Protein (H-FABP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Heart-type Fatty Acid-Binding Protein (H-FABP) antibodies in H-FABP level test of Cardiovascular disease (myocardial injury) and related syndrome evaluation. |
D dimer (D-Dimer)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
---|---|---|---|---|---|---|---|---|
Human |
D dimer |
GMP-h-D-Dimer-Ag01 |
D dimer (D-Dimer) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in D-Dimer level test of Cardiovascular disease (Deep vein thrombosis (DVT)) and related syndrome evaluation |
GMP-h-D-Dimer-Ab01;GMP-h-D-Dimer-Ab02:Anti-Human D-Dimer mouse monoclonal antibody (mAb) |
Human D dimer (D-Dimer) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other D dimer (D-Dimer) antibodies in D-Dimer level test of Cardiovascular disease (Deep vein thrombosis (DVT)) and related syndrome evaluation. |
Digoxigenin (Dig)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
---|---|---|---|---|---|---|---|---|
Human |
Digoxigenin |
GMP-h-Dig-Ag01 |
Digoxigenin (Dig) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Dig level test of Cardiovascular disease and related syndrome evaluation |
GMP-h-Dig-Ab01;GMP-h-Dig-Ab02:Anti-Human Dig mouse monoclonal antibody (mAb) |
Human Digoxigenin (Dig) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Digoxigenin (Dig) antibodies in Dig level test of Cardiovascular disease and related syndrome evaluation. |
Apolipoprotein A (ApoA)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
---|---|---|---|---|---|---|---|---|
Human |
Apolipoprotein A |
GMP-h-ApoA-Ag01 |
Apolipoprotein A (ApoA) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in ApoA level test of Cardiovascular disease (Cardiovascular Disease) and related syndrome evaluation |
GMP-h-ApoA-Ab01;GMP-h-ApoA-Ab02:Anti-Human ApoA mouse monoclonal antibody (mAb) |
Human Apolipoprotein A (ApoA) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Apolipoprotein A (ApoA) antibodies in ApoA level test of Cardiovascular disease (Cardiovascular Disease) and related syndrome evaluation. |
Apolipoprotein E (ApoE)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
---|---|---|---|---|---|---|---|---|
Human |
Apolipoprotein E |
GMP-h-ApoE-Ag01 |
Apolipoprotein E (ApoE) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in ApoE level test of Cardiovascular disease (Cardiovascular Disease) and related syndrome evaluation |
GMP-h-ApoE-Ab01;GMP-h-ApoE-Ab02:Anti-Human ApoE mouse monoclonal antibody (mAb) |
Human Apolipoprotein E (ApoE) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Apolipoprotein E (ApoE) antibodies in ApoE level test of Cardiovascular disease (Cardiovascular Disease) and related syndrome evaluation. |
B-type natriuretic peptide (BNP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
---|---|---|---|---|---|---|---|---|
Human |
B-type natriuretic peptide |
GMP-h-BNP-Ag01 |
B-type natriuretic peptide (BNP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in BNP level test of Cardiovascular disease (Cardiovascular Disease) and related syndrome evaluation |
GMP-h-BNP-Ab01;GMP-h-BNP-Ab02:Anti-Human BNP mouse monoclonal antibody (mAb) |
Human B-type natriuretic peptide (BNP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other B-type natriuretic peptide (BNP) antibodies in BNP level test of Cardiovascular disease (Cardiovascular Disease) and related syndrome evaluation. |
pro B-type natriuretic peptide (proBNP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
---|---|---|---|---|---|---|---|---|
Human |
pro B-type natriuretic peptide |
GMP-h-proBNP-Ag01 |
pro B-type natriuretic peptide (proBNP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in proBNP level test of Cardiovascular disease (intrinsic cardiac
dysfunction) and related syndrome evaluation |
GMP-h-proBNP-Ab01;GMP-h-proBNP-Ab02:Anti-Human proBNP mouse monoclonal antibody (mAb) |
Human pro B-type natriuretic peptide (proBNP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other pro B-type natriuretic peptide (proBNP) antibodies in proBNP level test of Cardiovascular disease (intrinsic cardiac
dysfunction) and related syndrome evaluation. |
Matrix Metalloproteinase Inhibitor-1 (TIMP-1)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
---|---|---|---|---|---|---|---|---|
Human |
Matrix Metalloproteinase Inhibitor-1 |
GMP-h-TIMP-1-Ag01 |
Matrix Metalloproteinase Inhibitor-1 (TIMP-1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in TIMP-1 level test of Cardiovascular disease (coronary artery stenosis, coronary
artery lesions) and related syndrome evaluation |
GMP-h-TIMP-1-Ab01;GMP-h-TIMP-1-Ab02:Anti-Human TIMP-1 mouse monoclonal antibody (mAb) |
Human Matrix Metalloproteinase Inhibitor-1 (TIMP-1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Matrix Metalloproteinase Inhibitor-1 (TIMP-1) antibodies in TIMP-1 level test of Cardiovascular disease (coronary artery stenosis, coronary
artery lesions) and related syndrome evaluation. |
C-type natriuretic peptide (CNP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
---|---|---|---|---|---|---|---|---|
Human |
C-type natriuretic peptide |
GMP-h-CNP-Ag01 |
C-type natriuretic peptide (CNP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CNP level test of Cardiovascular disease (cardiovascular disease) and related syndrome evaluation |
GMP-h-CNP-Ab01;GMP-h-CNP-Ab02:Anti-Human CNP mouse monoclonal antibody (mAb) |
Human C-type natriuretic peptide (CNP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other C-type natriuretic peptide (CNP) antibodies in CNP level test of Cardiovascular disease (cardiovascular disease) and related syndrome evaluation. |
human atrial natriuretic peptide (ANP)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
---|---|---|---|---|---|---|---|---|
Human |
human atrial natriuretic peptide |
GMP-h-ANP-Ag01 |
human atrial natriuretic peptide (ANP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in ANP level test of Cardiovascular disease (hypertension, cardiac
hypertrophy and heart failure) and related syndrome evaluation |
GMP-h-ANP-Ab01;GMP-h-ANP-Ab02:Anti-Human ANP mouse monoclonal antibody (mAb) |
Human human atrial natriuretic peptide (ANP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other human atrial natriuretic peptide (ANP) antibodies in ANP level test of Cardiovascular disease (hypertension, cardiac
hypertrophy and heart failure) and related syndrome evaluation. |
Angiotensin (AI)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
---|---|---|---|---|---|---|---|---|
Human |
Angiotensin |
GMP-h-AI-Ag01 |
Angiotensin (AI) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in AI level test of Cardiovascular disease (hypertension, renal
disease, and congestive heart failure) and related syndrome evaluation |
GMP-h-AI-Ab01;GMP-h-AI-Ab02:Anti-Human AI mouse monoclonal antibody (mAb) |
Human Angiotensin (AI) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Angiotensin (AI) antibodies in AI level test of Cardiovascular disease (hypertension, renal
disease, and congestive heart failure) and related syndrome evaluation. |
Vascular Endothelial Growth Factor (VEGF)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
---|---|---|---|---|---|---|---|---|
Human |
Vascular Endothelial Growth Factor |
GMP-h-VEGF-Ag01 |
Vascular Endothelial Growth Factor (VEGF) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in VEGF level test of Cardiovascular disease (angiogenesis) and related syndrome evaluation |
GMP-h-VEGF-Ab01;GMP-h-VEGF-Ab02:Anti-Human VEGF mouse monoclonal antibody (mAb) |
Human Vascular Endothelial Growth Factor (VEGF) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Vascular Endothelial Growth Factor (VEGF) antibodies in VEGF level test of Cardiovascular disease (angiogenesis) and related syndrome evaluation. |
recombinant human placental growth factor-1 (PLGF-1)
Cat No. | Species | Biomarker | Disease | Cat No.of Antigen | Bioactivity validation of Antigen | Cat No.of Antibodies | Bioactivity validation of Antibodies | Order |
---|---|---|---|---|---|---|---|---|
Human |
recombinant human placental growth factor-1 |
GMP-h-PLGF-1-Ag01 |
recombinant human placental growth factor-1 (PLGF-1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in PLGF-1 level test of Cardiovascular disease (angiogenesis) and related syndrome evaluation |
GMP-h-PLGF-1-Ab01;GMP-h-PLGF-1-Ab02:Anti-Human PLGF-1 mouse monoclonal antibody (mAb) |
Human recombinant human placental growth factor-1 (PLGF-1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other recombinant human placental growth factor-1 (PLGF-1) antibodies in PLGF-1 level test of Cardiovascular disease (angiogenesis) and related syndrome evaluation. |